feed,title,long_url,short_url
Benzinga,Westlake VP and CAO Trades $203K In Company Stock,https://benzinga.com/news/23/02/31093200/westlake-vp-and-cao-trades-203k-in-company-stock,https://da.gd/85sBB
Benzinga,EVP and CFO of Westlake Makes $361K Sale,https://benzinga.com/news/23/02/31093198/evp-and-cfo-of-westlake-makes-361k-sale,https://da.gd/Q6iKU6
Benzinga,Vigil Neuroscience Chief Science Officer Awarded $3.24M Worth of Stock Options,https://benzinga.com/news/23/02/31093196/vigil-neuroscience-chief-science-officer-awarded-3-24m-worth-of-stock-options,https://da.gd/J2IPwJ
Benzinga,"EVP at Amedisys Acquires Company Stock Options Worth 8,627 Shares",https://benzinga.com/news/23/02/31093194/evp-at-amedisys-acquires-company-stock-options-worth-8-627-shares,https://da.gd/4xaZxq
Benzinga,Amedisys Chief Compliance Officer Awarded $264K Worth of Stock Options,https://benzinga.com/news/23/02/31093192/amedisys-chief-compliance-officer-awarded-264k-worth-of-stock-options,https://da.gd/o23r8
Benzinga,Amedisys Chief Strategy Officer Awarded $264K Worth of Stock Options,https://benzinga.com/news/23/02/31093188/amedisys-chief-strategy-officer-awarded-264k-worth-of-stock-options,https://da.gd/CtsH
Benzinga,"Chief Information Officer at Amedisys Acquires Company Stock Options Worth 4,314 Shares",https://benzinga.com/news/23/02/31093175/chief-information-officer-at-amedisys-acquires-company-stock-options-worth-4-314-shares,https://da.gd/ow5jfE
Benzinga,"Chief People Officer at Amedisys Acquires Company Stock Options Worth 2,876 Shares",https://benzinga.com/news/23/02/31093172/chief-people-officer-at-amedisys-acquires-company-stock-options-worth-2-876-shares,https://da.gd/3nsSC
Benzinga,Enliven Therapeutics Chief Financial Officer Awarded $5.47M Worth of Stock Options,https://benzinga.com/news/23/02/31093163/enliven-therapeutics-chief-financial-officer-awarded-5-47m-worth-of-stock-options,https://da.gd/B7xth
Benzinga,"Chief Scientific Officer at Enliven Therapeutics Acquires Company Stock Options Worth 433,081 Shares",https://benzinga.com/news/23/02/31093158/chief-scientific-officer-at-enliven-therapeutics-acquires-company-stock-options-worth-433-081-shares,https://da.gd/5ST7ct
Benzinga,Enliven Therapeutics Chief Operating Officer Awarded $1.86M Worth of Stock Options,https://benzinga.com/news/23/02/31093155/enliven-therapeutics-chief-operating-officer-awarded-1-86m-worth-of-stock-options,https://da.gd/dj9RFh
Benzinga,Enliven Therapeutics Board Member Awarded $1.82M Worth of Stock Options,https://benzinga.com/news/23/02/31093154/enliven-therapeutics-board-member-awarded-1-82m-worth-of-stock-options,https://da.gd/oxDt
Benzinga,Enliven Therapeutics Chief Medical Officer Awarded $5.99M Worth of Stock Options,https://benzinga.com/news/23/02/31093152/enliven-therapeutics-chief-medical-officer-awarded-5-99m-worth-of-stock-options,https://da.gd/nbd32P
Benzinga,"President and CEO at Enliven Therapeutics Acquires Company Stock Options Worth 748,913 Shares",https://benzinga.com/news/23/02/31093150/president-and-ceo-at-enliven-therapeutics-acquires-company-stock-options-worth-748-913-shares,https://da.gd/0T6hpu
Benzinga,Enliven Therapeutics Director Awarded $430K Worth of Stock Options,https://benzinga.com/news/23/02/31093148/enliven-therapeutics-director-awarded-430k-worth-of-stock-options,https://da.gd/xneD
